Board Change • Jun 02
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. President, CEO & Director Andy Mattes was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • May 13
Second quarter 2022 earnings released: EPS: US$1.36 (vs US$6.49 loss in 2Q 2021) Second quarter 2022 results: EPS: US$1.36 (up from US$6.49 loss in 2Q 2021). Revenue: US$370.2m (down 1.0% from 2Q 2021). Net income: US$33.7m (up US$191.9m from 2Q 2021). Profit margin: 9.1% (up from net loss in 2Q 2021). The move to profitability was driven by lower expenses. Over the next year, revenue is forecast to grow 6.6%, compared to a 25% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 31% per year, which means it is well ahead of earnings. Buying Opportunity • Mar 16
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 2.4%. The fair value is estimated to be US$290, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.0% per annum over the last 3 years. The company became loss making over the last 3 years. Reported Earnings • Feb 10
First quarter 2022 earnings: EPS in line with expectations, revenues disappoint First quarter 2022 results: EPS: US$1.23 (up from US$0.006 in 1Q 2021). Revenue: US$384.5m (up 18% from 1Q 2021). Net income: US$30.3m (up US$30.1m from 1Q 2021). Profit margin: 7.9% (up from 0% in 1Q 2021). Revenue missed analyst estimates by 2.0%. Over the next year, revenue is forecast to grow 7.9%, compared to a 23% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 25% per year, which means it is well ahead of earnings. Executive Departure • Dec 01
Special Advisor John Ambroseo has left the company On the 1st of December, John Ambroseo was replaced as CEO by Andreas Mattes after 17.5 years in the role. As of September 2021, John still personally held 187.28k shares (€40m worth at the time). A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 1.58 years, which is considered inexperienced in the Simply Wall St Risk Model. Under John's leadership, the company delivered a total shareholder return of 414%. Reported Earnings • Nov 11
Full year 2021 earnings released: US$4.38 loss per share (vs US$17.18 loss in FY 2020) The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2021 results: Revenue: US$1.49b (up 21% from FY 2020). Net loss: US$106.8m (loss narrowed 74% from FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance. Reported Earnings • Aug 12
Third quarter 2021 earnings released: EPS US$1.24 (vs US$0.36 loss in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: US$395.8m (up 33% from 3Q 2020). Net income: US$30.3m (up US$39.0m from 3Q 2020). Profit margin: 7.6% (up from net loss in 3Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 104 percentage points per year, which is a significant difference in performance. Director Overboarding • Aug 05
Director Jay Flatley sitting on 4 company boards Jay Flatley has been appointed as the CEO of Zymergen Inc. (NasdaqGS:ZY). Flatley now sits on a total of 4 company boards. With 4 board positions including the role of CEO at Zymergen Inc. (NasdaqGS:ZY), the director is at risk of having too many board obligations according to the Simply Wall St Risk Model. Director Overboarding • Aug 05
Director Jay Flatley sitting on 4 company boards Jay Flatley has been appointed as the CEO of Zymergen Inc. (NasdaqGS:ZY). Flatley now sits on a total of 4 company boards. With 4 board positions including the role of CEO at Zymergen Inc. (NasdaqGS:ZY), the director is at risk of having too many board obligations according to the Simply Wall St Risk Model. Is New 90 Day High Low • Feb 14
New 90-day high: €184 The company is up 86% from its price of €99.16 on 13 November 2020. The German market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €54.48 per share. Analyst Estimate Surprise Post Earnings • Feb 12
Revenue beats expectations Revenue exceeded analyst estimates by 2.5%. Over the next year, revenue is forecast to grow 17%, compared to a 17% growth forecast for the Electronic industry in Germany. お知らせ • Nov 11
Coherent, Inc. Provides Financial Guidance for the First Quarter of 2021 Coherent, Inc. provided financial guidance for the first quarter of 2021. Revenue for fiscal first quarter is expected to be in the range of $300 million to $320 million. This revenue range reflects the current uncertainty in Europe with regard to the impact of the COVID resurgence and many countries in the region implementing some form of a lockdown. Is New 90 Day High Low • Nov 05
New 90-day high: €107 The company is up 1.0% from its price of €106 on 07 August 2020. The German market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is down 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €175 per share. お知らせ • Oct 29
Coherent, Inc. to Report Q4, 2020 Results on Nov 10, 2020 Coherent, Inc. announced that they will report Q4, 2020 results at 5:00 PM, Eastern Standard Time on Nov 10, 2020 お知らせ • Oct 03
Coherent, Inc. to Report Q3, 2019 Results on Jul 30, 2019 Coherent, Inc. announced that they will report Q3, 2019 results at 5:00 PM, Eastern Standard Time on Jul 30, 2019 Is New 90 Day High Low • Sep 18
New 90-day low: €90.14 The company is down 27% from its price of €124 on 19 June 2020. The German market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €170 per share. お知らせ • Jul 22
Coherent, Inc. to Report Q3, 2020 Results on Aug 04, 2020 Coherent, Inc. announced that they will report Q3, 2020 results at 5:00 PM, Eastern Standard Time on Aug 04, 2020